Top pharma company ditches direct supply

The company says it has listened to feedback from community pharmacists

AstraZenca is ditching direct supply of nine high-cost medicines, returning to exclusive distribution through wholesalers.

Astra Zeneca

The decision to stop using DHL is a response to “feedback from numerous community pharmacists”, says the company.

“Everyone asked for choice, a reliable, easy way to order and access all our medicines, and this updated distribution model will address your requirements,” the company told pharmacists in a statement.

The nine brands are:

  • Zoladex (goserelin acetate)
  • ZolaCos (goserelin-bicalutamide)